Table 2.
ATX-101 Treatment Parameters
| Patients (n = 12) | |
|---|---|
| Number of ATX-101 treatments, mean ± SD | 1.8 ± 0.9 |
| Received 1 treatment, n (%) | 5 (42) |
| Received ≥2 treatments, n (%) | 7 (58) |
| Interval between treatments, mean ± SD [range], daysa | 108.0 ± 76.4 [34–271] |
| Total ATX-101 volume, mean ± SD [range], mL | 13.9 ± 8.4 [6–36] |
| ATX-101 volume per treatment, mean ± SD [range], mL | 7.6 ± 2.4 [4–12] |
| Among patients who received 1 treatment | 8.4 ± 1.5 [6–10] |
| Among patients who received ≥2 treatments | 7.4 ± 2.5 [4–12] |
| Anesthesia, n (%)b | |
| General | 5 (42) |
| Local | 8 (67) |
| Volume per treatment, mean ± SD [range], mL | 3.9 ± 1.0 [2–5] |
| Oral analgesia | 8 (67) |
| Postinjection ice packs, n (%) | 12 (100) |
SD, standard deviation. aAmong patients who received ≥2 treatments. bPatients could receive both general and local anesthesia depending on concurrent treatments/procedures.